Judith M. Matthews - Mar 31, 2023 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Chief Financial Officer
Signature
/s/ Judith M. Matthews
Stock symbol
ITRM
Transactions as of
Mar 31, 2023
Transactions value $
$0
Form type
4
Date filed
4/3/2023, 08:00 PM
Previous filing
Mar 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Stock Option (Right to Buy) Award $0 +100K $0.00 100K Mar 31, 2023 Ordinary Shares 100K $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest at a rate of 33.3% of the total number of shares on the one-year anniversary of March 31, 2023 and the remaining 66.7% will vest in equal monthly installments thereafter until March 31, 2026, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.